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Abstract : This study was designed to
determine the prevalence of osteopathy in
diabetic patients, who are at risk of
developing osteopathy, and clarify the
relationship between osteopathy and other
complications of diabetes mellitus. Thirty-four
type I and 66 type II diabetic patients
admitted to the endocrinology clinic between
1996 and 1997 and 30 nondiabetic subjects
as a control group were studied. Bone
scintigraphy
(Tc
99m
methylene
diphosphonate) was used for the diagnosis of
osteopathy. The body mass index (BMI) of
each patient was calculated. Polyneuropathy
was assessed by electromyography and the
patients, for each of whom BMI was
calculated, were asked about the symptoms of
autonomic neuropathy and history of foot
ulcer, whereas cardiovascular autonomic
neuropathy was assessed by autonomic
neuropathy tests and calculated QTc
(corrected QT). Fundoscopy was performed
for evaluation of retinopathy. Biochemical
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Introduction
Diabetes mellitus is a state of hyperglycemia
characterized by impaired carbohydrate, lipid and protein
metabolism (1,2). In time, the musculoskeletal system
may also be damaged, in addition to many other systems.
Osteopathy is one of the complications of diabetes seen in
the musculoskeletal system, which is involved in advanced
disease.
Of the complications, foot problems are the most
common, and constitute the primary cause of admittance
to hospital in the diabetic population (3,4,5).
Diabetics are reported to have an osteopathy rate of
0.1-6.8% (6,7,8), whereas in patients with diabetic
neuropathy this rate increases to 77% (9).
The most important characteristic of osteopathy is

analysis was carried out for blood glucose,
HbA1c levels and microalbuminuria, an
indicator of nephropathy. We found that the
prevalence of osteopathy is 44% in diabetic
patients and the risk of osteopathy increases
with the duration of diabetes (p<0.05) and
the age of the patient (p<0.05). The risk was
found to be higher in females (p<0.05), and
no relationship between the body mass index
of the patient and blood glucose regulation
was observed. 76.9% of patients with history
of foot ulcer (p<0.01), 61% of patients with
retinopathy (p<0.01) and 68.8% of patients
with autonomic neuropathy (p<0.01) were
found to have osteopathy. Because osteopathy
may have devastating end results which can
be prevented if recognized early, we suggest
that all diabetics, especially those in the risk
group, must be screened for osteopathy and,
if required, they must receive proper
treatment.
Key Words: Diabetes Mellitus, Osteopathy,
Bone scintigraphy

that it has intermittant activity; it can stay in an inactive
stage for months or even years (10). Furthermore,
although complete healing is seen in some of the patients,
in others, progression of the disease may result in foot
ulceration and even amputation in the absence of
osteomyelitis (11). Thus the detection of osteopathy at an
earlier stage and therapy with intensive diabetes control
and nonweight-bearing of that foot will prevent this
undesirable outcome.
In this study, we investigated the prevalence of
osteopathy in diabetic people and the relationship
between diabetic osteopathy and age, sex, duration, type
and regulation of diabetes, microangiopathy, neuropathy
and foot ulcer history. We attempted to define criteria for
the determination of diabetic patients at risk of
developing osteopathy.
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Materials and Methods
Thirty-four type I (insulin dependent diabetes
mellitus) and 66 type II (non-insulin dependent diabetes
mellitus) patients who were admitted to the Ankara
Numune Hospital Endocrinology and Metabolism
Department between April 1996 and April 1997 were
included in the study. For each group (type I and type II)
15 nondiabetic volunteers were used as a control group.
The type I group consisted of 12 female and 22 male
patients with a mean age of 27.5 ± 1.4 years, and the
type II group comprised 47 female and 19 male patients
with a mean age of 54.4 ± 1.2 years.
The control-I group for type I patients consisted of 8
female and 7 male nondiabetic subjects with a mean age
of 32 ± 2.4 years, and the control-II group for type II
patients consisted of 9 female and 6 male nondiabetic
subjects with a mean age of 59.2 ± 1.9 years.
Patients with osseous lesions resembling diabetic
osteopathy, such as lepra, syringomyelia, tabes dorsalis,
scleroderma, hereditary sensorial syndrome and familial
amyloidosis, were excluded from the study. All patients
were evaluated clinically and by X-ray, and those who had
osteomyelitis and traumatic fractures were not included
in the study.
Osteopathy was assessed by bone scintigraphy, which
has been shown to be more sensitive than radiography in
the diagnosis of osteopathy (12,13,14). After injection of
20 mCi technetium 99m methylene diphosphonate (Tc
99m MDP), scintigraphic images were taken with an SPX6 Elscint gamma camera and low-energy all-purpose
collimator at 0 minutes (dynamic phase), 3-5 minutes
(blood pool), 3-4 hours and 24 hours (static phases). The
absence of bone radiopharmaceutical uptake at the
dynamic and blood pool phases, increased uptake at the
3rd hour and its constancy at the 24th hour static phase
without any change in uptake dose was interpreted as
diabetic osteopathy.
We used electromyography (EMG) with an MEB-7102
K model neuropack 2 (Nihon Kohden) device for the
diagnosis of polyneuropathy. The conduction velocity of
sensory and motor nerves, action potential amplitudes
and F wave latency of sensory and motor sensations were
studied in median, peroneal and sural nerve segments,
while sensory nerve conduction was studied in median
and sural nerves.
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Patients were asked whether they had had foot ulcer
at any time in their life, or symptoms of autonomic
neuropathy such as gastric atony, urinary retention,
rectal incontinence, diarrhea (other causes of diarrhea
were eliminated), impotence (for patients under the age
of 65 years) and also signs of orthostatic hypotension
were assessed. For the diagnosis of cardiovascular
autonomic neuropathy, QTc, which was calculated with
Bazzet’s formula (18), and cardiovascular autonomic
neuropathy tests were used (15). Other causes of long
QTc were eliminated (16,17).
Retinopathy was assessed by fundoscopy and, if
necessary,
by
fluorescein
angiography.
The
immunoprecipitation method was used for the detection
of microalbuminuria, which was interpreted as an
indicator of nephropathy (19).
HbA1c levels were measured by the latex
immunoagglutination inhibition method with Ames DCA
2000 TM HbA1c kits in DCA 2000 TM analyzer. Fasting
blood glucose was measured by the oxidation method;
urinary examination for glucose and ketone was carried
out with stripes.
In the statistical analysis of the relationship between
age, BMI and osteopathy, Kolmogorov-Smirnov test was
used; for the relationship of HbA1c and osteopathy, the ttest in independent samples was used; and for the
relationship between sex, type and duration of diabetes,
foot ulcer history, other complications of diabetes and
osteopathy, the Chi-square test was used, a p value of
less than 0.05 being considered significant. The results
are shown as “mean ± standard error”.

Results
With the scintigraphic imaging technique, 11 out of
34 type I diabetic patients (32.35%) and 33 of 66 type
II diabetic patients (50%) were found to have osteopathy.
No one in the control groups was found to have
osteopathy. The relationship between osteopathy and the
type of diabetes mellitus was statistically insignificant
(p>0.05).
In the type I diabetic patient group, 7 out of 12
female patients and 4 out of 22 male patients were found
to have osteopathy, while in the type II diabetic patient
group, 26 out of 47 female patients and 7 out of 19 male
patients were found to have osteopathy (Figure 1). While
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the relationship between osteopathy and the sex of
patients was found to be statistically significant in the
type I diabetic group (p<0.05), it was insignificant in the
type II diabetic group (p>0.05). In total, osteopathy was
detected in 31 out of 59 female patients and in 13 out of
41 male patients, and this female dominance was
statistically significant (p<0.05).
The mean age of all diabetic patients was 45 ± 15.86
years, 50.36 ± 17.05 years in patients with osteopathy
and 41.34 ± 13.75 years in patients without osteopathy.
It was found that the prevalence of osteopathy increases
with age (p<0.05) (Figure 2).
The body mass index (BMI) of each patient was
2
calculated as weight (kg)/height (m ). Six percent of
patients were obese, 37% overweight, 49% normal and
8% underweight. Osteopathy was found in 5 of obese
patients (83.3%), 15 of the overweight patients (40.5%)
and 24 of the normal-weight patients (49%), while none
of the underweight patients were found to have
osteopathy. The relationship between osteopathy and
BMI was insignificant (p>0.05).
Patients were grouped according to the duration
diabetes; 0-5 years for group I, 6-10 years for group
and 11 years and more for group III. The prevalence
osteopathy was found to increase with the duration
diabetes (p<0.05) (Figure 3).

of
II,
of
of

The mean HbA1c level in patients with osteopathy was
10.02 ± 2.02%, whereas in patients without osteopathy
it was 11.26 ± 2.08%. There was no relationship
between osteopathy and HbA1c levels (p>0.05).
A total of 34 patients had nephropathy, 38 patients
had retinopathy and 68 patients had polyneuropathy. Of
the 44 patients with osteopathy, 23 also had retinopathy
(52.27%), 34 had polyneuropathy (77.27%) and 21 had
nephropathy (47.7%). Although there was a significant
relationship between osteopathy and retinopathy
(p<0.01), no relationship was found between
nephropathy and polyneuropathy (p>0.05, p>0.05)
(Figure 4). Sixty four patients (64%) had autonomic
neuropathy and 44 of patients (68.7%) with autonomic
neuropathy had also osteopathy. There was a significant
relation between osteopathy and autonomic neuropathy
(p<0.01) Figure 5).
Ten out of 44 patients with osteopathy (22.7%) were
found to have foot ulcer history. Out of 13 patients with
a history of foot ulcer, only 3 said that they didn’t have

foot ulcer before. The relation between foot ulcer history
and osteopathy was significant (p<0.01) (Figure 6).

Discussion
Diabetic osteopathy, diabetic neuroarthropathy,
diabetic neuro-osteoarthropathy and diabetic Charcot’s
joint are all terms indicating the same pathology. After it
was shown that the primary pathology is in the bone and
that the joint deformities are secondary to this bone
pathology, “osteopathy” became the more widely used
term (6).
In 1831, Mitchell first identified this condition, and in
1868 Charcot began studying it (20). Since then, much
research on the pathogenesis of osteopathy has been
performed. In 1936, Jordan defined Charcot’s joint in
diabetic neuropathy (21). Oakley et al. classified foot
lesions in diabetic patients and also explained their
etiologies and treatment protocols (22). There are very
different reports about the prevalence of diabetic
osteopathy in the literature. In our study, 44% of all
diabetic patients, 50% of patients with polyneuropathy
and 68% of patients with autonomic neuropathy were
found to have osteopathy. In 1962, Boehm, in a review
of the literature, found only 52 cases with osteopathy
(23). Pogonovska and his colleagues reported either bone
destruction or generalized osteoporosis in the feet of
6.8% of 242 diabetic patients (6). Gondos examined all
diabetics admitted to a large municipal hospital for 10
years and found only 36 cases of osteopathy (10).
Friedman and Rakow reported that the prevalence of
osteopathy was 77% in patients with diabetic neuropathy
(9). Sinha et al. found Charcot’s joint in 100 out of
68000 diabetic patients (24). Smith reported the
prevalence of Charcot changes as 1.4% (8). In this study,
while BMI, type of diabetes and blood glucose regulation
were shown to have no effect on the diabetic osteopathy,
we found the risk of osteopathy to increase with the age
of the patient and the duration of diabetes; in the type I
diabetic group, the risk was found to be higher in females
than males.
This can be explained by faster bone formation in
younger patients. Bone formation is a slow process and in
time, destruction exceeds formation, which brings up the
importance of the time factor (10). Oackley et al. also
found a close relationship between foot lesions and age,
but in his report, the duration and the severity of the
257
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diabetes were found to be unimportant (22). Lithner et
al. reported a higher prevalence of osteopathy in type I
diabetics (32%) than in type II diabetics (17%) and
suggested that there was no relationship with the age and
sex of the patients (25). Williams et al. stated that there
was no relationship between osteopathy and the age of
the patient or the duration of diabetes, but in their study
a large majority of patients were type II diabetics: 50 type
I, 145 type II (26).
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Figure 6.

The relationship between osteopathy and foot ulcer history
in diabetic patients.

According to Ellenberg, osteopathy is a messenger of
flared up diabetes. In such a case, it is expected to find
increased nephropathy, retinopathy, peripheral neuritis,
and cardiovascular and gastrointestinal system
impairment (27,28). Nonetheless, in our study, we found
no relationship between osteopathy and polyneuropathy
or nephropathy. The only consistent finding with
Ellenberg’s claim was that 52.3% of patients with
diabetic osteopathy also had retinopathy.
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We determined that 10 of (76.9%) 13 patients with
a history of foot ulcer had osteopathy and decided that
these patients form a risk group for diabetic osteopathy.
In a retrospective study, Cavanagh and colleagues
suggested that foot ulcers cause a high risk of residual
bone abnormalities, but they were unable to determine
the relative time of ulceration and bone abnormalities.
They found the prevalence of traumatic fracture, bone
destruction and amputation in the neuropathic ulcer
group to be higher than in the neuropathic nonulcer
group (29).
Four hypotheses have been suggested for the etiology
of osteopathy: the primary metabolic bone disease
theory, the ischemia theory, the neurotraumatic theory
and the neurovascular theory.
Because it was shown that osteoblastic activity was
normal and bone structure returned to normal
spontaneously or with nonweight-bearing of the foot, the
primary metabolic bone disease theory became invalid.
The ischemia hypothesis also seems impossible due to the
fact that the density of ischemic bone does not change.
Osteoporosis, osteosclerosis and new bone formation
need good circulation (11). Nowadays the most
acceptable theory in the literature is the neurotraumatic
theory. According to this theory, bone changes are
secondary to loss of protective sensation (pain, heat and
proprioception) of the foot and joints (4). There are
reports claiming that repeated minor traumas result in
neuroarthropathy in joints with impaired proprioceptive
sensation (3,24,30). In our study, 10 out of 44 patients
(22.7%) with osteopathy had no polyneuropathy and the
relationship between osteopathy and polyneuropathy was
insignificant. We were unable to explain the mechanism of
osteopathy with this theory in these 10 patients.
However, 44 patients with osteopathy had autonomic
neuropathy, which can only be explained by the
neurovascular theory.
According to the neurovascular theory, the neurally

initiated vascular reflex causes increased blood flow in
bone and active bone resorbtion by osteoclasts; fractures
and joint deformities are secondary to this event. Leriche
showed that lesions in sympathetic nerves cause
hyperemia and bone atrophy (31). Shim detected
increased bone blood flow in dogs following lumbar
symphatectomy or incision of sciatic nerve, which carries
sympathetic fibers (32). Schwarz et al. reported left
neuropathic foot following left symphatectomy in a
diabetic patient (33). It was reported that blood flow
increases in neuropathic foot and symphatetic
denervation causes significant vasodilation and
arteriovenous shunt (34,35). Also, histopathologic
evaluation of osteopathic bone revealed fusion and
widening of the Haversian canals, expanded blood vessels,
increased number of osteoclasts and active resorption
(11,36,37). Our study supports the neurovascular theory
against the neurotraumatic one. Serra et al. also reported
that reabsorption due to osteoclasis and increased blood
flow until osteomalasia appears are the characteristics of
this arthropathy (38).
In conclusion, we found that older age, long duration
of diabetes, history of foot ulcer, retinopathy, autonomic
neuropathy and, for IDDM patients, female sex are the
risk factors for diabetic osteopathy. We suggest that
every diabetic patient, especially the ones with risk
factors, even if their blood glucose regulation is good,
must be examined for osteopathy, because osteopathy
has devastating end results which can be prevented with
appropriate precautions.
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